Irritable Bowel Syndrome Clinical Trial
— REACHOfficial title:
Randomized Controlled Trial of an Internet-based Prevention Intervention for Parents With Irritable Bowel Syndrome
The goal of this clinical trial is to test efficacy of the REACH program in parents with irritable bowel syndrome (IBS) and their young children. The main question it aims to answer is: -How can parents with IBS help their young kids develop healthy habits? Participants will be asked to complete online surveys and to use a website. Researchers will compare results from parents who use one of two websites chosen by chance, like flipping a coin. One website focuses on child health and safety behaviors. The other website focuses on strategies to promote child wellness behaviors.
Status | Recruiting |
Enrollment | 460 |
Est. completion date | April 30, 2027 |
Est. primary completion date | October 31, 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion criteria for parents and their children (including biological/step-parents or legal guardians): - Parent/caregiver at least 18 years old - Parent diagnosed with IBS or idiopathic abdominal pain in the last five years OR - Parent meets ROME criteria for IBS (abdominal pain at least weekly; pain related to defecation, change in stool frequency, and change in stool form at least 30% of the time) - Is the parent primarily responsible for caring for the child on a day-to-day basis - Child is 4 to 7 years old at the time of screening. If multiple children are present in the family, the parent will be asked to select one child for study participation. - Child must currently live at least half of the time with the parent involved in intervention. - Parent and child must reside in the U.S. Exclusion criteria for parents and their children: - Not able to read/speak/understand English. - Child has a developmental disability that requires full-time special education - Child has chronic abdominal pain (pain most/every day for more than 3 months) - Child has a current doctor's diagnosis of a painful* gastrointestinal disorder like functional constipation, lactose/fructose/gluten intolerance, celiac disease, Inflammatory Bowel Disorder, etc. (*does not include nonpainful disorders like GERD) - Child has another severe chronic disease such as juvenile arthritis, cancer, or other severe condition(s) requiring chronic medical treatment. - Does not have regular access to the Internet on a desktop, tablet, phone, or laptop computer |
Country | Name | City | State |
---|---|---|---|
United States | Seattle Children's Hospital | Seattle | Washington |
Lead Sponsor | Collaborator |
---|---|
Seattle Children's Hospital | University of Washington |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in parental encouragement of child illness behavior | Assesses self-reported parental encouragement of child illness behavior. The Adult Responses to Child Symptoms (ARCS) has 29-items that load onto 3 subscales (Protectiveness, Monitoring/Encouragement, Minimization). Responses are rated on a 5-point scale ranging from "never" to "always." . Higher average scores indicate that the responses are more frequently used, and thus higher scores are less adaptive ways of responding. | Baseline, 4-6 weeks, 6 months post-intervention, 12 months post-intervention, and 18 months post-intervention | |
Secondary | Change in anxiety | Parent self-report. The Generalized Anxiety Disorder (GAD2) is one of the most frequently used diagnostic self-report scales for screening, diagnosis and severity assessment of anxiety disorders in adults. The scale is based on two items which are scored from 0 to 3, with higher scores indicating greater anxiety symptoms. | Baseline, 4-6 weeks, 6 months post-intervention, 12 months post-intervention, and 18 months post-intervention | |
Secondary | Change in pain catastrophizing | Parent self-report. Pain Catastrophizing Scale, is a 13-item measure that assesses catastrophizing thoughts or feelings accompanying the experience of pain. Respondents are asked to reflect on past painful experiences and to indicate the degree to which each of the 13 thoughts or feelings were experienced when in pain. Responses are from 0 (not at all) to 4 (all the time) with higher scores indicating higher levels of catastrophizing. | Baseline, 4-6 weeks, 6 months post-intervention, 12 months post-intervention, and 18 months post-intervention | |
Secondary | Change in positive and negative affect | Parent self-report. Positive and Negative Affect Schedule (PANAS) is a widely used self-report measure that is made up of two mood scales. One 10-item scale measures positive affect and the other 10-item scale measures negative affect on a 5-point Likert scale. Scores range from 10-50 for each scale with higher scores indicating high levels of positive or negative affect. | Baseline, 4-6 weeks, 6 months post-intervention, 12 months post-intervention, and 18 months post-intervention | |
Secondary | Change in perceived social support | Parent self-report. Perceived Social Support will be assessed using the Multidimensional Scale of Perceived Social Support (MSPSS). This scale consists of 12 items that measure the extent of social support received from 3 sources: friends, family, and significant others. Types of social support assessed by the MSPSS include emotional, tangible, informational, social network support, and esteem. Scores range from 12 to 84 with higher scores indicating greater social support. | Baseline, 4-6 weeks, 6 months post-intervention, 12 months post-intervention, and 18 months post-intervention | |
Secondary | Change in health-related quality of life | Parent proxy report and child self-report (ages 7+). The Pediatric Quality of Life Inventory (PedsQL) is a brief measure of health-related quality of life in children. The measure can be completed by parents (the Proxy Report) for children as young as age 2 years. The 23 items in the PedsQL comprise four Generic Core Scales: Physical Functioning (8 items), Emotional Functioning (5 items), Social Functioning (5 items), and School Functioning (5 items). Two Summary Scores can be computed (the Psychosocial Health Summary Score and the Physical Health Summary Score), as well as a Total Scale Score. Scores range from 0-100, with higher scores indicating better quality of life. | Baseline, 4-6 weeks, 6 months post-intervention, 12 months post-intervention, and 18 months post-intervention | |
Secondary | Change in health care costs | Parents will complete the Client Service Receipt Inventory (CSRI), a validated comprehensive inventory of health care services incurred due to the child's symptoms that uses a standard response timeframe of the past 6 months. In the CSRI, parents report on three sources of health care costs: direct medical service use, direct non-medical costs, and indirect costs. In order to better estimate costs, monetary values will be assigned to health resources use and productivity time loss data captured in the CSRI. All expenditures will be converted to 2023 dollars using the medical care component of the Consumer Price Index available from the Bureau of Labor Statistics. Costs will be aggregated across the three sources to derive total costs for analyses. | Baseline, 6 months post-intervention, 12 months post-intervention, and 18 months post-intervention | |
Secondary | Change in pain intensity | Parent proxy report and child self-report (ages 7+). The Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Intensity form includes three items assessing child's pain intensity in the past 7 days. | Baseline, 4-6 weeks, 6 months post-intervention, 12 months post-intervention, and 18 months post-intervention | |
Secondary | Change in somatic symptoms | Parent proxy report. The Children's Somatic Symptoms Inventory (CSSI-8) includes 8 items assessing the severity of a child's nonspecific somatic symptoms. The set of GI symptoms (pain, nausea, upset stomach) are used to measure GI symptom severity. | Baseline, 4-6 weeks, 6 months post-intervention, 12 months post-intervention, and 18 months post-intervention | |
Secondary | Change in abdominal pain symptoms | Parent proxy report. The ROME Functional Abdominal Pain questions include 5 items assessing ROME criteria for upper and lower functional abdominal pain - frequency, severity, location, and association with eating (lower only). | Baseline, 4-6 weeks, 6 months post-intervention, 12 months post-intervention, and 18 months post-intervention | |
Secondary | Change in depressive symptoms | Parent self-report. The Patient Health Questionnaire (PHQ2) includes 2 items inquiring about the degree to which an individual has experienced depressed mood and anhedonia over the past two weeks. | Baseline, 4-6 weeks, 6 months post-intervention, 12 months post-intervention, and 18 months post-intervention | |
Secondary | Change in parenting stress | Parent self-report. The Daily Parenting Hassles Scale is a 20-item scale that assesses parent burden in meeting the needs of their children and troublesome behavior of children. Subscales include challenging behavior and parenting tasks. | Baseline | |
Secondary | Number of treatment contacts | The administrative backend of the intervention programs has a tracking system for recording use of the program. Specifically, we will measure: 1) logins to the program, 2) completed treatment modules, and 3) completed assignments. | 0-6 weeks | |
Secondary | Treatment acceptability | The TEI-SF is a 9-item measure that assesses treatment acceptability and satisfaction. Select items were adapted to be specific to a parenting prevention program (e.g., "I find this intervention to be an acceptable way of dealing with young children's health"). Items are rated on a 5-point scale (1 = 'strongly disagree', 5 = 'strongly agree') and summed to create a total score, with higher scores indicating higher acceptability and satisfaction. | 4-6 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03720314 -
Microbiota Profiling in IBS
|
||
Recruiting |
NCT06166563 -
Exercise, Irritable Bowel Syndrome and Fibromyalgia
|
N/A | |
Completed |
NCT05213910 -
Study of a Management Strategy of Functional Bowel Disordes Related to Irritable Bowel Syndrome (IBS) With a Mixture of 8 Microbiotic Strains
|
N/A | |
Recruiting |
NCT05985018 -
Traditional Dietary Advice Vs. Mediterranean Diet in IBS
|
N/A | |
Completed |
NCT04486469 -
Efficacy of Physiotherapy Techniques on Irritable Bowel Syndrome (IBS). Pilot Study.
|
N/A | |
Completed |
NCT06407609 -
Positive Outcomes of the Supplementation With Lecithin-based Delivery Form of Curcuma Longa and of Boswellia Serrata in IBS
|
N/A | |
Completed |
NCT04656730 -
Effect of STW5 (Iberogast ®) and STW5-II (Iberogast N®) on Transit and Tolerance of Intestinal Gas
|
Phase 4 | |
Completed |
NCT04145856 -
Combination of Alverine-simeticone and i3.1 Probiotic in IBS-D and IBS-M in Mexico
|
Phase 4 | |
Recruiting |
NCT04138225 -
The Ecological Role of Yeasts in the Human Gut
|
||
Active, not recruiting |
NCT03586622 -
One Year Home Monitoring and Treatment of IBS Patients
|
N/A | |
Completed |
NCT05207618 -
Utility of the Administration of Chesnut and Quebracho Extract for Irritable Bowel Syndrome Diarrhea Predominant
|
N/A | |
Not yet recruiting |
NCT06369753 -
Visible Abdominal Distension
|
N/A | |
Not yet recruiting |
NCT05157867 -
In Vivo Effects of Amylase Trypsin Inhibitors
|
N/A | |
Not yet recruiting |
NCT05100719 -
The Role of Irritable Bowel Syndrome in Lactose Intolerance (LION)
|
N/A | |
Recruiting |
NCT05001997 -
Effects of Lactose-free Dairy Products on Athletes With Irritable Bowel Syndrome
|
N/A | |
Recruiting |
NCT02953171 -
Probiotics in the Treatment of Irritable Bowel Syndrome
|
N/A | |
Completed |
NCT02977975 -
Lacto-fermented Sauerkraut in the Treatment of Irritable Bowel Syndrome
|
N/A | |
Completed |
NCT03266068 -
Epidemiology and Pathophysiology of Post-Infectious Functional GI Disorders
|
||
Completed |
NCT02980406 -
The Role of FODMAPs in Upper GI Effects, Colonic Motor Activity and Gut-brain Signaling at the Behavioral Level
|
N/A | |
Completed |
NCT03318614 -
Bifidobacterium Infantis M-63 Improves Mental Health in Irritable Bowel Syndrome Developed After a Major Flood Disaster
|
Phase 2/Phase 3 |